Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/51141
Conference/Presentation Title: | Prevalence of vitamin C deficiency in adult hospital patients in high-income countries: A scoping review. | Authors: | Golder J.;Bauer J.;Barker L.;Lemoh C. ;Gibson S.;Davidson Z. | Monash Health Department(s): | Allied Health | Institution: | (Golder, Bauer, Barker, Davidson) Nutrition, Dietetics and Food, Monash University (Golder) Allied Health, Monash Health (Lemoh) Department of Medicine, Monash University (Lemoh) Department of Medicine, Western Health (Gibson) School of Clinical Sciences, Monash University, Melbourne, Australia |
Presentation/Conference Date: | 7-Feb-2024 | Copyright year: | 2023 | Publisher: | Elsevier Ltd | Publication information: | Clinical Nutrition ESPEN. Conference: ESPEN 2023. Lyon France. 58(pp 613), 2023. Date of Publication: December 2023. | Journal: | Clinical Nutrition ESPEN | Abstract: | Rationale: With emerging evidence indicating vitamin C deficiency (VCD) is present in community settings of high-income countries, there is growing interest in understanding the prevalence of VCD during hospitalisation, in order to prevent deficiency progression to scurvy and other clinical outcomes associated with VCD. This study aimed to explore the prevalence of VCD in adult hospitalised patients, describe patient characteristics, and identify associated risk factors and clinical outcomes. Method(s): A systematic scoping review was conducted following the PRISMA-ScR framework. Six databases were searched. Eligibility included hospital inpatients in high-income countries and VCD prevalence using World Health Organisation reference standards (plasma/serum concentration <11.4 mumol/L, whole blood <17 mumol/L). Cumulative prevalence of VCD in pooled studies was calculated using REVMAN 5.4. Result(s): Twenty-two studies from 8 countries were included, representing 23 articles. Cumulative prevalence of VCD was 26.6% (95% CI: 20.7-32.5; n=2494), prevalence was highest in patients with severe illness and poor nutrition status, and scurvy was present in 18-48% (n=581) of VCD patients. VCD status did not resolve during admission unless therapeutically replaced. Being retired (p=0.015), and taking excessive alcohol and tobacco (p=0.0003) were independent risk factors for VCD (n=184); clinical outcomes included increased risk of frailty (aOR 4.3, 95% CI 1.33-13.86, p=0.015) and cognitive impairment (aOR 2.93, 95% CI 1.05-8.19, p=0.031; n=160). Two studies examined nutrition associations with VCD (n=309); results were inconsistent. Conclusion(s): High prevalence of VCD exists in adult hospitalised patients in high-income countries. Research which focuses on early detection, and examination of VCD prevalence in a broader range of hospital settings and patient groups is warranted. Disclosure of Interest: None declaredCopyright © 2023 | Conference Name: | ESPEN 2023 | Conference Start Date: | 2023-09-11 | Conference End Date: | 2023-09-14 | Conference Location: | Lyon, France | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1016/j.clnesp.2023.09.550 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/51141 | Type: | Conference Abstract | Subjects: | ascorbic acid deficiency cognitive defect epidemiology frailty scurvy |
Type of Clinical Study or Trial: | Review article (e.g. literature review, narrative review) |
Appears in Collections: | Conferences |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.